You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Modest weight loss does not decrease cardiovascular morbidity and mortality in adults with type 2 diabetes
  1. Nichola J Davis,
  2. Gayotri Goswami
  1. Department of Medicine, North Central Bronx Hospital, Bronx, New York, USA
  1. Correspondence to : Dr Nichola J Davis, Department of Medicine, North Central Bronx Hospital, 3424 Kossuth Avenue, Bronx, NY 10461, USA; nichola.davis{at}nbhn.net

https://doi.org/10.1136/eb-2013-101518

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Wing RR, Bolin P, Brancati FL, et al. Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369:145–54.OpenUrlCrossRefPubMedWeb of Science

    Context

    Diet, physical activity and weight loss are recommended in the management of type 2 diabetes. This recommendation is largely based on short-term intervention studies which show improvements in cardiovascular risk factors including glycaemic control, lipids, blood pressure and inflammation. The Look AHEAD (Action for Health in Diabetes) randomised controlled trial (RCT) studied the impact of long-term weight loss through an intensive lifestyle intervention on cardiovascular morbidity and mortality in type 2 diabetes.

    Methods

    Look AHEAD is a multicentre, RCT. A total of 5145 adults aged 45–75 years with type 2 diabetes were randomised to receive either an intensive lifestyle intervention (n=2570) or control (n=2575). The intervention …

    View Full Text

    Footnotes

    • Competing interests None.